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*Author for correspondenceMyosin binding protein-C (MyBP-C), also known as C-
protein, is a major constituent of the thick filaments of ver-
tebrate striated muscles. The protein, ~130 kDa, consists of
a series of 10 globular motifs (numbered I to X) each of
~90-100 amino acids, bearing resemblance to the C2-set of
immunoglobins (Ig C2) and to the fibronectin type III
(FnIII) motifs. Using pure preparations of myosin and
MyBP-C, it has been demonstrated that the major myosin
binding domain of MyBP-C resides within the C-terminal
Ig C2 motif (motif X). However, in the context of the in vivo
thick filament, it is uncertain if the latter domain is suffi-
cient to target MyBP-C correctly to the A-band or if other
regions of the molecule are required for this process. To
answer this question, cultures of skeletal muscle myoblasts
were transfected with expression plasmids encoding seven
truncation mutants of MyBP-C, and their targeting to the
A-band investigated by immunofluorescence microscopy.
To distinguish the recombinant proteins from endogenous
MyBP-C, a myc epitope was inserted at each amino
terminus. Recombinant MyBP-C exhibited an identical dis-
tribution in the sarcomere to that of native MyBP-C; i.e. it
was found exclusively in the C-zone of the A-band. A
mutant encoding the C-terminal 372 amino acids, but
lacking motifs I-VI (termed D 1-6), also targeted correctly
to the A-band. This fragment, which is composed of two Ig
C2 and two FnIII motifs, was the minimal protein fragment
required for correct A-band incorporation. Larger amino-
terminal deletions or deletion of motif X, the myosin
binding domain, abolished all localization to the A-band.
One construct (D 10) lacking only motif X strongly inhibited
myofibril assembly. We conclude that the myosin binding
domain of MyBP-C, although essential, is not sufficient for
correct incorporation into the A-band and that motifs VII
to IX are required for this process. The data suggest a topo-
logical model in which MyBP-C is associated with the thick
filament through its C terminus.
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SUMMARYINTRODUCTION
The myofibrils of the vertebrate striated muscles are complex,
semi-crystalline structures consisting of interdigitating thin and
thick filaments predominantly composed of actin and myosin,
respectively, and of a battery of myofibril associated proteins
having structural and/or regulatory functions (reviewed by
Epstein and Fischman, 1991; Small et al., 1992). Besides
myosin, at least eight different proteins have been found in
association with vertebrate thick filaments: (1) titin (Maruyama
et al., 1977; Wang et al., 1979; reviewed by Trinick, 1992); (2)
skelemin (Price et al., 1993); (3) M-protein (Masaki and
Takaiti, 1974; Trinick and Lowey, 1977; Noguchi et al., 1992);
(4) myomesin (Grove et al., 1985); (5) MM-creatine kinase
(Wallimann et al., 1983); (6) AMP-deaminase (Cooper and
Trinick, 1984); (7) MyBP-H (H-protein) (Starr and Offer,
1983; Bahler et al., 1985; Bennett et al., 1986) and MyBP-C
(C-protein) (Offer et al., 1973).
MyBP-C is a relatively large protein (~130 kDa) that repre-
sents about 2% of myofibrillar protein (Offer et al., 1973). It
is located in the A-bands of the thick filaments of all vertebratecross-striated muscles, where it is restricted to a series of 7-9
transverse stripes, 43 nm apart, in the cross-bridge bearing
region (Craig and Offer, 1976; Dennis et al., 1984; Bennett et
al., 1986). Several isoforms of MyBP-C that are fiber-type
specific or expressed at selected stages of development have
been identified. In the chicken, for example, at least six
different isoforms have been characterized (Takano-Ohmuro et
al., 1989). We and others have cloned and sequenced several
isoforms of MyBP-C from various organisms (Einheber and
Fischman, 1990; Fürst et al., 1992; Weber et al., 1993; Okagaki
et al., 1993; Gautel et al., 1995). From the deduced primary
structure, MyBP-C has been predicted to contain a series of
globular domains, based on repetitive motifs, each 90-100
amino acids in length, which bear resemblance to the C2-set
of the immunoglobulin superfamily (Ig C2) and the fibronectin
type III motif (FnIII). In the case of MyBP-C, seven Ig C2 and
three FnIII motifs are present (Fig. 1). One of the best charac-
terized biochemical properties of MyBP-C is its relatively
strong affinity for myosin (Offer et al., 1973; Moos et al.,
1975). Using an in vitro binding assay, we have shown that the
principle myosin binding domain of MyBP-C resides within
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highly conserved among the C- and H-protein families
(Okagaki et al., 1993). MyBP-C also binds to titin and weakly
to actin (Moos et al., 1978; Yamamoto, 1986; Fürst et al., 1992;
Koretz et al., 1993). Although MyBP-H binds to myosin it does
not appear to bind titin (Soteriou et al., 1993).
The precise function of MyBP-C is uncertain but evidence
exists for both structural and regulatory roles. When compared
with other myofibrillar proteins, MyBP-C appears relatively
late during myofibril assembly in both cultured skeletal
(Kawashima et al., 1986; Lin et al., 1994) and cardiac muscle
(Schultheiss et al., 1990; Rhee et al., 1994). It is first detected
by immunofluorescence in A-bands as non-striated myofibrils
(NSMFs) (Lin et al., 1994) or nascent myofibrils (Rhee et al.,
1994) transform into mature myofibrils. Since the expression of
MyBP-C correlates with the emergence of cross-striations, the
protein may be a regulatory component in the assembly
reaction, potentially as a rate-limiting molecule. When purified
myosin is polymerized in vitro, at physiological stoichiometries
with MyBP-C, the resulting thick filaments are slightly longer
and more regular than in the absence of MyBP-C (Koretz, 1979;
Davis, 1988). The presence of MyBP-C reduces the critical con-
centration required for myosin polymerization, suggesting that
it may regulate thick filament assembly (Davis, 1988). This is
consistent with the observation that co-expression of MyBP-C
or MyBP-H with myosin heavy chain in COS cells promotes
the formation of long cable-like co-polymers of both proteins
(Seiler et al., 1996). Deletion of the C-terminal Ig C2 motif from
MyBP-C or MyBP-H prevents such cable formation.
The observation that MyBP-C inhibits actin-activated
skeletal muscle myosin ATPase but stimulates actin-activated
cardiac muscle myosin ATPase (Offer et al., 1973; Moos and
Feng, 1980; Yamamoto and Moos, 1983; Hartzell, 1985)
suggests a potential role in the regulation of contraction. The
cardiac isoform of MyBP-C is phosphorylated by a cate-
cholamine-sensitive pathway and this phosphorylation corre-
lates with the rate of twitch relaxation (Hartzell and Titus,
1982; Hartzell, 1984). The reactive serine residues have been
identified but the precise kinase awaits characterization (Gautel
et al., 1995). Furthermore, partial extraction of MyBP-C from
myofibrils enhances tension generation at submaximal con-
centrations of Ca2+ and accelerates the contractile velocity at
low levels of Ca2+ activation (Hofmann et al., 1991a,b). Both
changes are reversible upon the reinsertion of MyBP-C.
It is clear that better knowledge of the various biochemical
properties of MyBP-C and their precise mapping on the protein
is crucial to understand the function as well as the mechanism
of action of MyBP-C. As described above, the major myosin
binding domain of MyBP-C has been mapped to the C-terminal
Ig C2 motif of the protein (motif X). However, in the context
of the in vivo thick filament, it is uncertain if the latter domain
is sufficient to target the protein to the A-band. It is likely,
because of the complexity of the thick filament, that other
regions of MyBP-C are important for correct localization to the
A-band. To address this question, we have analyzed the
expression and distribution of seven truncation mutants of
MyBP-C in cultured skeletal myoblasts. We show here that a
mutant encoding the last 372 amino acids at the C terminus
(33% of the full length protein) is efficiently and correctly
incorporated into the A-band. This fragment, consisting of two
Ig C2 and two FnIII motifs (motifs VII-X), is the minimallength required for correct targeting to the C-zone of the A-
band. Larger deletions at the amino terminus or deletion of
motif X, the myosin binding domain, abolished localization to
the A-band. We conclude that the myosin binding domain of
MyBP-C, although essential, is not sufficient for correct incor-
poration into the A-band and that motifs VII to IX are required
for this process. The data suggest a topological model in which
MyBP-C is associated with the thick filament through its C
terminus; sequences nearer the N terminus may subserve prop-
erties associated with thin filament interactions.
MATERIALS AND METHODS
Vector constructs
Recombinant DNA procedures followed standard methods
(Sambrook et al., 1989). The mutations and the junctions of the
spliced regions were confirmed by double-stranded DNA sequencing,
using the protocols and the reagents provided by the Sequenase
sequencing kit (United States Biochemical). Unless otherwise
specified, the primers and enzymes were purchased from New
England Biolabs. The cDNA encoding the full length MyBP-C
(Einheber and Fischman, 1990; Okagaki et al., 1993) was cloned into
the EcoRI site of pBluescript II SK+/– (Stratagene) and the
polyadenylation signal removed by digestion with exonuclease III.
The cDNA was ligated to XbaI linkers, and cloned into the XbaI site
of the expression vector pJDp- (Mikawa et al., 1992). This plasmid
was called pJDC. To construct a cDNA encoding a myc epitope at
the N terminus of MyBP-C (MyBP-Cmyc), the three bp at the 5 ¢ end
of the initiation codon were mutated to create a NdeI restriction site.
The cDNA was digested with NdeI and the ends were filled in by
reaction with the large fragment of DNA polymerase I (Klenow). The
cDNA was then excised by digestion with NotI and inserted into the
SmaI and NotI sites of pBSmyc. Plasmid pBSmyc was generated by
inserting the oligonucleotide 5¢ -AAGCTTGGGCGACCTCAC-
CATGGAGCAAAAGCTCATTTCTGAAGAGGACTTGAATTC-3¢ ,
encoding the myc epitope (Munro and Pelham, 1986), into the HindIII
and EcoRI sites of pBluescript II KS+/- (Stratagene). The plasmid
encoding MyBP-Cmyc was digested with XhoI and filled in with
Klenow. The cDNA was excised by digestion with NotI and cloned
into the SmaI and NotI sites of pJDC. This plasmid was called pMC.
To construct D 1-2, pMC was digested with XmnI and filled in by
reaction with Klenow. The 3¢ portion of MyBP-C was excised by
digestion with XbaI and inserted into the EcoRI and XbaI sites of
pBSmyc. Before ligation, the EcoRI ends were filled in with Klenow.
The plasmid encoding D 1-2 was digested with HindIII and filled in
with Klenow. The insert was removed by digestion with XbaI and
cloned into the SmaI and XbaI sites of pJDp- . To construct D 1-6, a
NheI linker (5¢ -CTAGCTAGCTAG-3¢ ) was inserted into the AccI site
at position 2,303 of pMC. The 3¢ portion of MyBP-C was isolated by
digestion with NheI and XbaI, and cloned into the EcoRI and XbaI
sites of pBSmyc. Before ligation, the NheI and the EcoRI ends were
filled in with Klenow. The plasmid encoding D 1-6 was digested with
HindIII and filled in with Klenow. The insert was removed
by digestion with XbaI and cloned into the SmaI and XbaI sites of
pJDp- . To construct D 1-8, pMC was digested with NotI and filled in
with Klenow. The 3¢ portion of MyBP-C was excised by digestion
with XbaI and cloned into the EcoRI and XbaI sites of pMC. Before
ligation, the EcoRI ends were filled in with Klenow. The plasmid
encoding D 1-8 was digested with HindIII and filled in with Klenow.
The insert was removed by digestion with XbaI and cloned into the
SmaI and XbaI sites of pJDp - . To construct mutant D 1-9, pET-C2, a
plasmid encoding the 14 kDa peptide (Okagaki et al., 1993) was
digested with NcoI and filled in with Klenow. The insert was excised
by digestion with BamHI and cloned into the SmaI and BamHI sites
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and filled in with Klenow. The insert was removed by digestion with
XbaI and cloned into the SmaI and XbaI sites of pJDp- . Mutants D 10,
D 9-10 and D 7-10 were constructed by inserting a NheI linker (5¢ -
CTAGCTAGCTAG-3¢ ) encoding a termination codon in any of the
three reading frames. To construct D 10 and D 7-10, the linker was
inserted into the AccI sites at position 3,014 and 2,303 of pMC,
respectively. In the case of D 7-10, the 3 ¢ end of the cDNA was
removed by digestion with NheI and XbaI. Mutant D 9-10 was con-
structed by inserting the linker in the unique NotI site of pMC.
Western blots
Canine fibroblasts (D17, available from ATCC) were grown at 37°C
under an atmosphere of 2% CO2 in Dulbecco’s modified Eagle’s
medium (DME) supplemented with 7% FBS, glutamine and antibi-
otics. D17 and primary cultures of myoblasts (see below) were trans-
fected with a mixture of LipofectAMINE (Gibco BRL) and DNA
according to the manufacturer’s recommendations. The next day
(D17) or three days later (myoblasts), the cells were washed with PBS
and lysed with hot (80°C) 2· sample buffer (Laemmli, 1970) con-
taining 2 mM of PMSF and 2 m g/ml of aprotinin. The chromatin was
sheared by several passages through a 20G1 needle. The samples were
then boiled for 3 minutes and separated by electrophoresis using the
Laemmli system (Laemmli, 1970) in either 7, 12, or 15% SDS-PAGE
gels. The proteins were transferred to nitrocellulose membranes
overnight at 4°C in 25 mM Tris-HCl, 192 mM glycine, 20% methanol,
pH 8.3 (Harlow and Lane, 1988). In some experiments, to improve
the transfer of positively charged proteins, such as D 1-9, the proteins
were transferred to nitrocellulose membranes according to the method
of Szewczyk and Kozloff (1985). The membranes were then
incubated with mAbs specific for the chicken fast isoform of MyBP-
C (MF1; Reinach et al., 1982) or for the myc epitope (9E10; Evan et
al., 1985), and then with horseradish peroxidase-labeled affinity-
purified goat anti-mouse antibodies (Sigma). The antibody complex
was visualized by chemiluminescence (Dupont).
Myoblast cultures and immunofluorescence microscopy
Myoblasts were isolated from the pectoralis muscles (PM) of chicken
(embryonic day (E) 11) and grown as described (Nawrotzki et al.,
1995). After isolation, they were plated in collagen-coated 4 cm2
Chamber-Slides (Nunc, Inc.) at a density of 4.0· 105 cells/chamber.
The next day the myoblasts were transfected with a mixture of Lipo-
fectAMINE (Gibco BRL) and DNA according to the manufacturer’s
recommendations. One to three days later, they were fixed with 2%
paraformaldehyde for 10 minutes and permeabilized with 1% Triton
X-100 for 10 minutes at room temperature. For immunofluorescence,
the cells were incubated with selected primary antibodies for 30
minutes at room temperature. The following primary antibodies were
used: MF1, a mAb against the chicken fast isoform of MyBP-C,
isotype IgG 1 (Reinach et al., 1982); 9E10, a mAb against the myc
epitope, isotype IgG 1 (Evan et al., 1985); T11, a mAb against the
chicken titin, isotype IgG 2b (Sigma; Fürst et al., 1988); F59, a mAb
against the S1 fragment of chicken skeletal myosin heavy chain,
isotype IgG 1 (Miller et al., 1989). To study the distribution of the
recombinant proteins and myosin, the cells were incubated with MF1
or 9E10, followed by Texas Red-conjugated affinity-purified rabbit
anti-mouse IgG 1 antibodies (Hyclone). They were then incubated with
F59 conjugated to biotin (Harlow and Lane, 1988), followed by FITC-
conjugated avidin (Cappel). The cells were fixed with 2%
paraformaldehyde for 5 minutes and mounted in 50% glycerol in PBS
containing 100 mg/ml of 1,4-diazabicyclo-[2.2.2]octane (Sigma). To
study the distribution of the recombinant proteins and titin, the cells
were incubated with MF1 or 9E10 followed by Texas Red-conjugated
affinity-purified rabbit anti-mouse IgG 1 antibodies (Hyclone). They
were then incubated with T11, followed by FITC-conjugated affinity-
purified rabbit anti-mouse IgG 2b antibodies (Hyclone), fixed and
mounted as described above. Specimens were observed with a Nikonepifluorescence microscope using 60· and 100· objectives. The
following filters were used: a filter block for FITC (UV-1A, Nikon), a
filter block for Texas Red (G-1B, Nikon), and a dual filter block
allowing visualization of Texas Red and FITC simultaneously (XF53,
Omega Optic). Photographs were taken using Kodak TMAX 400 or
Ektachrome 400 films.
Statistical analysis
To study the effects of the truncation mutants on myofibril assembly,
myoblasts were transfected and processed for immunofluorescence 3
days later as described above. The percentage of cells expressing the
truncation mutants and having cross-striated myofibrils as observed
after staining for myosin or titin was determined for each chamber.
The data obtained from 3 to 5 independent transfections were
analyzed. For each construct, 6 to 7 chambers were examined and
between 286 and 482 transfected cells were scored. The data were
analyzed by an analysis of variance followed by the test of Scheffé
(Woolson, 1987). 
RESULTS
Description of the MyBP-C truncation mutants
Our first step was to generate and characterize several truncation
mutants of MyBP-C. The mutants, depicted in Fig. 1, were con-
structed by deleting portions of the 5¢ and 3¢ coding region of the
cDNA encoding the chicken fast isoform of MyBP-C (Einheber
and Fischman, 1990; Okagaki et al., 1993). High expression of
the recombinant proteins was achieved in tissue culture by sub-
cloning the various cDNAs into the plasmid pJDp- . This plasmid
encodes the promoter and the 5¢ untranslated sequence of the
spleen necrosis virus which produces strong, constitutive
expression of cDNAs in most eukaryotic cells (Mikawa et al.,
1991, 1992). During differentiation in culture, the mononucleated
myoblasts fuse and begin to express a battery of myofibril asso-
ciated proteins including three different variants of MyBP-C:
cardiac, slow and fast isoforms (Kawashima et al., 1986). To dis-
tinguish the recombinant proteins from the endogenous isoforms
of MyBP-C, a short linker encoding a myc epitope of 12 amino
acids was inserted at the 5¢ end of each expressed cDNA (Fig.
1). Hereafter, the recombinant full length MyBP-C containing the
myc epitope is referred to as MyBP-Cmyc. 
Mutant D 1-2 was constructed by deleting Ig C2 motifs I and
II, except for 15 amino acids of the latter motif. Mutant D 1-6
lacks motifs I to VI and 29 amino acids of motif VII. To create
mutant D 1-8, motifs I to VII were deleted as well as 54 amino
acids of motif VIII. Mutant D 1-9 contains only motif X, which
contains the major myosin binding domain of MyBP-C
(Okagaki et al., 1993). Except for the presence of the myc
epitope, mutant D 1-9 is identical to the recombinant 14 kDa
fragment previously described. Mutant D 10 was constructed by
deleting motif X plus 15 amino acids of motif IX. To create
mutant D 9-10, motifs IX and X were deleted along with 27
amino acids of motif VIII. Mutant D 7-10 was generated by
deleting motifs VII to X except for 29 amino acids of motif
VII.
Before studying the distribution of MyBP-Cmyc and its trun-
cation mutants in cultured skeletal myoblasts, we examined the
size and antigenicity of the expressed proteins. Fibroblasts
were transfected with plasmids encoding MyBP-C, MyBP-
Cmyc and the truncation mutants. At selected time points the
cells were then lysed and analyzed by western blotting. As a
control, extracts of pectoralis muscle (PM) of chicken embryos
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Fig. 1. Expression constructs used in the present study. The numbers
above each protein correspond to the first and last amino acids,
starting from the N-terminus (left). The numbers below MyBP-C
indicate the position of each Ig C2 (C2) and fibronectin type III
(FnIII) motif. The position of the myc epitope at the N terminus is
shown. The distribution of each protein was investigated in well
differentiated myotubes and their presence in the A-band is indicated. 
Fig. 2. Evidence for the expression of the recombinant proteins in
cultured cells. (A) Fibroblasts transfected with plasmids without any
insert (- ), coding for MyBP-C (MyBP-C), coding for MyBP-C
containing the myc epitope (MyBP-Cmyc), or coding for the mutants
described in Fig. 1, were analyzed by SDS-PAGE. The proteins were
then transferred to a nitrocellulose membrane and subsequently
reacted with mAbs specific for MyBP-C (anti-C) or for the myc
epitope (anti-myc). Muscle: lane containing a lysate of the PM of
chicken embryos (E 20); Arrow: position of the product encoded by
D 1-9. (B) Mock transfected myoblasts (- ) or myoblasts transfected
with D 1-9 were analyzed by SDS-PAGE three days after transfection.
The expressed peptide was identified with mAbs specific for the myc
epitope (anti-myc, arrow). Numbers on the left of each gel indicate
the relative mobility of molecular mass markers (kDa). (E20) were analyzed simultaneously. When the blots were
incubated with MF1, a mAb specific for MyBP-C, a single
product of 130 kDa was detected in cells transfected with
MyBP-C or with MyBP-Cmyc (Fig. 2A). This product migrated
with the same mobility as endogenous MyBP-C in the PM. Its
size and reactivity with MF1 clearly indicated that it corre-
sponded to MyBP-C. No MyBP-C antigen was observed when
mock transfected cells or cells transfected with pJDp- were
used. As expected, a band of 130 kDa was detected when
lysates of cells expressing MyBP-Cmyc were analyzed using
the mAb against the myc epitope. This band was not observed
when extracts of cells expressing MyBP-C were analyzed, thus
demonstrating the specificity of the anti-myc antibody.
When cells expressing the truncation mutants were analyzed
with western blots, the seven constructs generated proteins
migrating on SDS-PAGE with the predicted mobilities (Fig.
2A). Mutants D 1-2, D 10, D 9-10 and D 7-10 were recognized by
MF1 and by the anti-myc antibody, whereas mutants D 1-6, D 1-
8, and D 1-9 were recognized solely by the anti-myc antibody.
The latter observation indicates that the MF1 epitope lies
between repeats II and VII (between amino acids 329 and 761).
Except for D 7-10 and D 1-9, the mutants appeared as single,
sharp and intense bands on each blot. When cells expressing
D 7-10 were analyzed, more than one band was observed; the
larger and more intense of these bands corresponded in size
with the expected product of D 7-10. The other bands may
represent partial degradation products, suggesting that D 7-10
is slightly less stable than the other truncated proteins. In the
case of D 1-9, the band corresponding to the expected product
was relatively faint and often difficult to detect. The theoreti-cal isoelectric point of D 1-9 (9.8) could have rendered the
protein difficult to transfer.
However, when the pH of the transfer buffer was increased
from 8.8 to 11, the signal intensity was only slightly improved,
suggesting that other factors, e.g. low level of expression or
protein degradation, could be responsible for poor detectability
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tiated myotubes, cultures of myoblasts were transfected with this
truncation mutant. Three days later the cells were lysed and
analyzed by western blots. A protein band migrating with an
approximative molecular mass of 14 kDa was detected on the
membrane indicating that D 1-9 was correctly expressed (Fig. 2B). 
The intracellular distribution of recombinant 
MyBP-C
To test if recombinant MyBP-C would incorporate into the A-
bands of the cross-striated myofibrils, myoblasts were isolated
from chicken embryos (E11) and transfected with a plasmid
encoding MyBP-Cmyc. Two to three days after transfection, the
time required for the myoblasts to fuse and to form myotubes
with robust cross-striated myofibrils, the cells were fixed andFig. 3. Evidence for the incorporation of recombinant MyBP-C into A-b
(E,F), were processed for immunofluorescence. The cells were double im
myosin (A-D), or for MyBP-C and myosin (E,F). The left row of figures
endogenous MyBP-C (E) using the Texas Red channel. The right row sh
channel. In young myotubes the recombinant MyBP-C is localized to the
myotubes, the recombinant and endogenous MyBP-C are localized to th
E: higher magnification illustrating that both the recombinant and the en
(arrows). Bars, 20 m m.processed for immunofluorescence. The distribution of MyBP-
Cmyc was assessed by staining the cells with a mAb against the
myc epitope, and the distribution of MyBP-C compared with
myosin and titin, by double labeling the cells with mAbs
specific for these latter proteins. Since the conclusions reached
with mAbs against myosin or titin were similar, only the pho-
tomicrographs obtained after labeling with anti-myosin are
presented below.
In the few myoblasts that did not differentiate or in the
scattered fibroblasts within the muscle cultures, MyBP-Cmyc
was homogeneously distributed in the cytoplasm, not associ-
ated with any obvious cellular structures. As the myoblasts dif-
ferentiated MyBP-Cmyc became associated with non-striated
myofibrils (NSMFs), also known as nascent myofibrils (Fig.
3A,B). The NSMFs are precursors of cross-striated myofibrilsands. Myoblasts transfected with MyBP-Cmyc (A-D), or not transfected
munostained with mAbs specific for the myc epitope and sarcomeric
 indicates the distribution of the recombinant (A,C) and the
ows the distribution of myosin in the same cells within the FITC
 NSMFs which are positive for myosin ( arrows, A,B). In more mature
e A-bands of the cross-striated myofibrils (arrows, C-F). Insets in C and
dogenous MyBP-C are distributed as doublets within each A-band
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titin, actin, a -actinin, tropomyosin and the troponin complex
(Einheber and Fischman, 1991; Rhee et al., 1994; Lin et al.,
1994). In differentiated myotubes MyBP-Cmyc staining wasFig. 4. Distribution of mutants with deletions at the N terminus. Myobla
D 1-9 (G,H) were processed for immunofluorescence three days after tran
the myc epitope and sarcomeric myosin. The left row shows the distribu
row indicates the distribution of myosin in the same cells (FITC channel
myofibrils (arrows, A-D), whereas most of the product of D 1-8 remains d
(arrows, F). Mutant D 1-9 distributes as a diffuse pattern in the cytoplasm
magnifications illustrating that D 1-2 and D 1-6 are distributed as A-band confined to the A-bands of myofibrils, since these same regions
of the sarcomere co-stained with mAbs against myosin (Fig.
3C,D). At the resolution of the light microscope, the distribu-
tion of MyBP-Cmyc was identical to that of endogenoussts transfected with mutants D 1-2 (A,B), D 1-6 (C,D), D 1-8 (E,F) and
sfection. The cells were double immunostained with mAbs specific for
tion of the recombinant proteins (Texas Red channel), whereas the right
). Mutants D 1-2 and D 1-6 are localized to the A-bands of cross-striated
iffuse in the cytoplasm (E) and was not incorporated into the A-band
 (G), not localized to the A-band (arrows, H). Insets in A and C: higher
doublets (arrows). Bars, 20 m m. 
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Fig. 5. Distribution of mutants with deletions at the C terminus. Myoblasts transfected with mutants D 10 (A,B), D 9-10 (C,D) and D 7-10 (E,F)
were processed for immunofluorescence three days after transfection. The cells were double immunostained with mAbs specific for the myc
epitope and sarcomeric myosin. The left row of figures show the distribution of recombinant proteins (Texas Red channel), while the right row
shows the distribution of myosin within the same cells (FITC channel). The mutants are distributed diffusely in the cytoplasm and not localized
to the A-band (arrows, B,D,F). Bar, 20 m m. MyBP-C (compare Fig. 3C,E). Both proteins stained as
doublets, one fluorescent stripe in each half A-band (insets Fig.
3C,E). In the transfected myotubes, when cross-striated
myofibrils were clearly apparent, MyBP-Cmyc was always
detected within the A-bands of cross-striated myofibrils. No
example of transfected cells with mature cross-striated myofib-
rils lacking MyBP-Cmyc in the A-bands was ever observed.
These data suggest that MyBP-Cmyc was as effectively incor-
porated into the A-bands of the cross-striated myofibrils as
endogenous MyBP-C, presumably as these structures were
assembled.
Cytoplasmic distribution of the truncation mutants
To identify those domains of MyBP-C containing the infor-
mation required for incorporation of the protein into A-bands,myoblasts were transfected with a series of MyBP-C trunca-
tion mutants. In well differentiated myotubes, D 1-2 and D 1-6
were identified as fluorescent doublets (Fig. 4A,D), one stripe
in each half A-band (insets, Fig. 4A,C). In the light microscope
the distribution of these two mutants was indistinguishable
from that of MyBP-Cmyc. Thus, the six N-terminal motifs of
MyBP-C are not required for A-band targeting of the complete
molecule. Presumably, the C-terminal peptide of 372 amino
acids, consisting of motifs VII to X, contains sufficient infor-
mation to specify correct incorporation of MyBP-C into the A-
band. When myotubes were stained using the anti-myc
antibody, the intensity of the cross-striations in cells express-
ing D 1-2 was similar to that observed in cells expressing
MyBP-Cmyc. However, the fluorescent signal was slightly
weaker in cells expressing D 1-6, suggesting that either less
108 R. Gilbert and othersprotein was incorporated into these A-bands, or that the avail-
ability of the myc epitope was obscured in the D 1-6 peptide
after A-band incorporation. 
Mutant D 1-8 did not target to the A-bands of the cross-
striated myofibrils (Fig. 4E,F). Most of the product of D 1-8
remains diffuse in the cytoplasm, although a weak accumula-
tion of protein was observed at the level of the I-band. This
weak signal in the I-band was demonstrated by observing the
cells with a filter permitting dual visualization of the FITC and
the Texas Red signals simultaneously (data not shown). Mutant
D 1-8 was the only protein found in detectable amounts within
the I-band and the reason for this is not understood. In well
differentiated myotubes, D 1-9 was diffusely distributed in the
cytoplasm and not detected in either the A- or I-bands (Fig.
4G,H). In comparison with the other truncation mutants, the
signal intensity in cells expressing D 1-9 was quite weak, con-
sistent with western blot data suggesting low levels of
expression and/or an unstable protein product. The fact that
neither D 1-8 nor D 1-9 was localized to the A-band was unex-
pected, since these two mutants contain the C-terminal Ig C2
motif encoding the myosin binding domain of MyBP-C.
Similarly, the mutants lacking one or more motifs at the C
terminus (D 10, D 9-10 and D 7-10) were not localized to the A-
band. Instead, they remained diffusely distributed in the
myotube sarcoplasm (Fig. 5A,F). These observations suggest
that although the myosin binding domain (motif X) is required
for proper incorporation of MyBP-C into the A-band, this
domain alone is insufficient to properly target the protein in
muscle cells containing the wild-type MyBP-C. 
Cells expressing mutant D 10 did not assemble robust cross-
striated myofibrils. Rather, the myotubes expressing significant
levels of D 10 contained fewer nuclei and were smaller in length
and diameter than comparably aged control myotubes. Cross-
striated myofibrils were observed in only 3% of the cellsWT ∆1−2 ∆1−6 ∆1−8 ∆1−9 ∆10 ∆9−10 ∆7−10
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Fig. 6. Effects of the truncation mutants on myofibril assembly.
Myoblasts were isolated and transfected with plasmids encoding
MyBP-Cmyc (WT) and the truncation mutants. Three days later, the
cells were processed for immunofluorescence and the percentage (%)
of cells expressing the recombinant proteins and having cross-
striated myofibrils was determined. Data represent average value;
bars represent one standard deviation; **average different from WT
(P<0.005); *average different from WT (P<0.01). expressing D 10, in comparison with a figure of 53% in
myotubes expressing MyBP-Cmyc (Fig. 6). When cross-striated
myofibrils were present in the cells expressing D 10, these were
shorter and contained fewer sarcomeres than the myofibrils in
adjacent, untransfected cells (Fig. 5A,B). Expression of mutant
D 9-10 also had a negative effect on the myoblast differentiation
program or the assembly of the myofibrils, but this effect was
less dramatic than that of mutant D 10 (Fig. 6).
DISCUSSION
This study demonstrates that recombinant MyBP-C can be effi-
ciently incorporated into the A-bands of the myofibrils after
transient expression in cultured embryonic skeletal muscle. As
judged by light microscopy, the distribution of the recombi-
nant protein is identical to that of endogenous MyBP-C. The
experiments prove that ~60% of the N-terminal portion of
MyBP-C (motifs I-VI) is unnecessary for A-band incorpora-
tion. A large deletion at the N terminus generating a C-terminal
peptide of 372 amino acids, encoding part of motif VII and all
of motifs VIII to X (mutant D 1-6), permits faithful A-band
insertion. This peptide is the minimal requirement for A-band
insertion, since mutations with larger deletions from the N
terminus, or mutants lacking the C terminus, do not localize to
the A-band. These observations indicate that motifs VII to X
are both necessary and sufficient for incorporation of MyBP-
C into the C zone of the A-band. Based on these data we
propose a model in which MyBP-C makes contact with, and is
positioned on, specific thick filament sites by repeats VII to X
(Fig. 7). We further suggest that the N-terminal section of
MyBP-C does not interact with the myosin backbone of the
thick filament, or does so very weakly, since this portion of the
molecule does not distribute to the A-band if it lacks the CNH NH3 3
COO COO- -
+ +
Thin filament
Thick filament
MyBP-C
10 nm
I I
VIII VIII
II II
III III
IV IV
V V
VI VI
VII VII
X X
IX IX
Fig. 7. Hypothetical model indicating the positioning of MyBP-C on
the thick filament. The preceding data suggest that MyBP-C is
associated with the thick filament through motifs VII to X at the C
terminus of each MyBP-C. In this model, the N-terminal moiety does
not bind to the thick or to the thin filament in resting muscle. The
sites on the thick filament where the molecules of MyBP-C are
localized are separated from each other by 43 nm (Dennis et al.,
1984; Bennett et al., 1986). Although rough estimates suggest the
presence of two to three molecules of MyBP-C at each of these sites
(Dennis et al., 1984; Hartzell and Sale, 1985), for diagrammatic
purposes only one molecule is indicated. In this model the C
terminus of MyBP-C is depicted as laying on the surface of the thick
filament but none of our data preclude embedment of motif X in the
thick filament. Roman numerals indicate the position of the Ig C2
and FnIII motifs of MyBP-C (see Fig. 1).
109Domains of MyBP-Cterminus (mutants D 9-10 and D 7-10). It should be recognized,
however, that the A-band signal of D 1-6 is weaker than that of
full length MyBP-C or of D 1-2, suggesting that D 1-6 is incor-
porated less efficiently into the A-band than the longer peptides
or its myc epitope is less accessible to its antibody probe.
Another possibility is that the myc epitope itself interferes with
peptide incorporation into the thick filament, for as seen in the
model presented in Fig. 7, the epitope is close to the filament
backbone in D 1-6 and might alter the binding reaction between
the expressed peptide and the myosin rod. 
Although the function of MyBP-C in vivo is uncertain,
evidence exits for roles in both the regulation of contraction
and in myofibril assembly. These two functions are not
mutually exclusive; separate domains of the molecule may
subserve different physiological properties. MyBP-C binds rel-
atively weakly to filamentous actin; i.e. with a Kd in the micro-
molar range (Moos et al., 1978; Yamamoto, 1986). Also,
MyBP-C alters positively or negatively the actomyosin
ATPase activity of cardiac and skeletal muscles, respectively.
MyBP-C might modify the interactions between myosin and
actin, or directly affect thin filament functions (Offer et al.,
1973; Moos and Feng, 1980; Yamamoto and Moos, 1983;
Hartzell, 1985). When purified fractions of MyBP-C are
observed by transmission electron microscopy, the molecules
appear as flexible rods with dimensions of 3 nm · 32 nm
(Hartzell and Sale, 1985; Swan and Fischman, 1986), or 4 nm
· 50 nm (Fürst et al., 1992). Since the distance between the
surface of the thin and the thick filaments ranges between 9
and 16 nm (Julian et al., 1978), the protein could span the inter-
filament gap, even if 30% of MyBP-C is bound to the thick
filament. Thus, the model proposed in Fig. 7 would permit
direct interactions between MyBP-C and both thick and thin
filaments, and be consistent with contractile regulation. The
most highly conserved segment of MyBP-C is an 18 amino
acid stretch between motifs I and II (Weber et al., 1993). The
high degree of conservation of this portion of the molecule and
its proposed topology near the thin filament (Fig. 7), suggests
that it could be involved in the regulation of contraction. In
support of this hypothesis, the cardiac isoform of MyBP-C is
phosphorylated by a catecholamine-sensitive pathway and this
phosphorylation correlates with the rate of twitch relaxation
(Hartzell and Titus, 1982; Hartzell, 1984). The phosphorylated
serines have been mapped to the N terminus between motifs I
and II (Gautel et al., 1995). 
When purified myosin is polymerized in vitro with physio-
logical concentrations of MyBP-C, the resulting thick filaments
are slightly longer and more regular than filaments assembled
in the absence of MyBP-C (Koretz, 1979; Davis, 1988). Fur-
thermore, when COS cells are co-transfected with two cDNAs,
one encoding MyBP-C and the other the myosin heavy chain
(MyHC), MyBP-C promotes the formation of long myosin-
containing, cytoplasmic cables (Seiler et al., 1996). In view of
the fact that MyBP-C appears relatively late in myofibrillo-
genesis, and that its expression coincides with the first appear-
ance of cross-striations (Lin et al., 1994; Schultheiss et al.,
1990), we suggest that MyBP-C might function as a rate-
limiting component of A-band assembly. Since MyBP-C
interacts with the thick filament through motifs VII to X at its
C terminus, the latter domain is likely to be directly involved
in the assembly reaction. 
Mutants D 1-9 and D 1-8 do not localize to the A-band. Thiswas a surprising observation since both proteins encode the
myosin binding domain of MyBP-C. Detection of D 1-9 by
western blots was difficult and the signal observed by immuno-
fluorescence microscopy was relatively weak, suggesting low
expression or protein instability. However, D 1-8 was easily
detected by both procedures indicating that low expression or
instability was not the reason for its absence in the A-band.
Although we cannot rule out the possibility that D 1-8 and D 1-
9 do not fold properly once expressed, it is more likely that
they fail to be incorporated into the A-band because of lower
affinities for myosin binding sites than endogenous MyBP-C.
This agrees with in vitro binding studies, in which it has been
observed that a peptide encoding the myosin binding domain
of MyBP-C does not displace MyBP-C from reconstituted
thick filaments, nor does it compete with MyBP-C for the
myosin binding sites in a mixture of both proteins (Okagaki et
al., 1993). Conceivably, motifs VII and VIII encode subtle
myosin binding activities which are required for correct incor-
poration into myofibrils, but these were not detected earlier
because they function in concert with motif X. This would
explain why none of the mutants lacking motif X were incor-
porated into the A-band. 
MyBP-C also binds to titin (Fürst et al., 1992; Koretz et al.,
1993; Soteriou et al., 1993), the huge filamentous molecule
thought to be associated with the surface of the thick filament
(Maruyama et al., 1977; Wang et al., 1979; reviewed by
Trinick, 1992; Small et al., 1992). Conceivably, both the titin
and myosin binding domains of MyBP-C are required for the
incorporation of MyBP-C into the thick filament. According to
this hypothesis, mutant D 1-6 would be correctly incorporated
into the A-band because it possesses both the titin and myosin
binding domains, whereas mutants D 1-8 and D 1-9 do not,
because they encode only the latter domain. The titin binding
domain on MyBP-C has not been mapped but it should now
be feasible to assess its localization within repeats VII and
VIII, as the previous hypothesis implies. 
We have also observed that myotubes expressing D 10 rarely
assemble cross-striated myofibrils and when myofibrils were
observed, these were shorter and contained fewer striations
than adjacent, untransfected myotubes. Mutant D 9-10 also
possesses a negative effect on either the myoblast differen-
tiation program or myofibril assembly, however, this effect is
less dramatic than that of D 10. The common characteristic of
these two mutants is the absence of motif X which contains the
major myosin binding domain of MyBP-C. The mechanism for
this negative effect is not understood. One possibility is that
D 10 and D 9-10 compete with endogenous MyBP-C, or another
myofibrillar protein, for an essential binding site on titin or
myosin needed for myofibril assembly. 
In normal development, MyBP-C is expressed relatively late
in myofibrillogenesis (Kawashima et al., 1986; Schultheiss et
al., 1990; Lin et al., 1994; Rhee et al., 1994). When MyBP-C
is detected, it is always localized in a typical doublet in the A-
bands. This observation is compatible with its involvement in
late stages of myofibril assembly, possibly as a rate limiting
factor. In concordance with this, when cross-striations were
apparent in cells expressing recombinant MyBP-C, the latter
protein was always limited to the C-zone of the A-band.
Recombinant MyBP-C was also detected in NSMFs, also
termed nascent myofibrils, which do not contain typical A-
bands and which are the likely precursors of cross-striated
110 R. Gilbert and othersmyofibrils (Lin et al., 1994; Rhee et al., 1994). To our
knowledge, this is the first report showing that MyBP-C can
be incorporated into NSMFs. There are several possibilities to
explain the presence of recombinant MyBP-C in the NSMFs:
(a) the concentration of recombinant protein may have been
insufficient to trigger full assembly of the A-bands in the
NSMFs; (b) the cells may have been caught in the midst of A-
band assembly; (c) the precocious expression of MyBP-C
alone may not be sufficient to trigger A-band assembly. Other
myosin binding proteins, e.g. MyBP-H, myomesin and M-
protein may act cooperatively with MyBP-C in late stages of
myofibril assembly. Thus, the latter protein may be one of the
late appearing proteins needed for the transition of NSMFs to
mature cross-striated myofibrils. Further work is needed to dis-
criminate between these possibilities.
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